Christopher Walsh

Co-founder and CEO/CTO of TileBio, a University of Glasgow spinout building the next generation AI foundation model for pathology. Our self-learning system transforms whole-slide images into a language of cancer, enabling pan-cancer triage tools for the clinic and biomarker discovery for drug development. 

Contact 

Christopher Walsh